A closer look at antimicrobial stewardship, a fundamental One Health issueAugust 12, 2024The goal is to ensure veterinarians help in minimizing the development of antimicrobial resistance (AMR), protecting our patients, and the future health of other animals, people, and the environment.
SPONSORED CONTENTYour Parasite Protection Recommendation, SimplifiedManaging parasite prevention doesn’t have to be complicated. Discover a single solution that protects against multiple threats. + Learn More
FIP, radiation, and other advances key to practicesAugust 5, 2024It is not always easy keeping up with what is happening and new in veterinary medicine. Four experts share more about recent advances in the field that could affect your practice.
First generic oral solution for feline hyperthyroidism receives FDA approvalJuly 15, 2024Felanorm, with active ingredient methimazole, is supplied in 30 mL or 100 mL bottles, with a 1 mL dosing syringe for treatment of feline hyperthyroidism.
Oral medication to treat FIP now available in the U.S.June 14, 2024The compounded medication, GS-441524, is now available in a quad-scored, 50-mg tuna-flavored tablet and can be prescribed to manage feline infectious peritonitis (FIP)
Looking beyond promotional claimsJune 14, 2024 Acting uncritically on promotional claims and other information supplied by the marketing company may lead to inadequate or misinformed prescribing decisions.
Canine platelet-rich plasma injectable gets FDA clearanceApril 30, 2024The off-the-shelf product is intended to provide a canine-specific source of concentrated platelets in plasma for intra-articular administration in dogs.
Post-procedural pain medication gets label extension from the FDAApril 12, 2024An extended-release buprenorphine injectable suspension indicated for mice, rats, ferrets, Ethiqa XR gets the U.S. Food and Drug Administration (FDA) green light for use in non-human primates (NHPs)
Reconsidering antibiotic duration for canine aspiration pneumoniaMarch 29, 2024Extended antibiotic therapy is not an unreasonable idea. New research is whittling away the recommended duration of antibiotics for canine aspiration pneumonia. Is there, in fact, good evidence for recommendations for long duration of antibiotic therapy for aspiration pneumonia?
$45M additional funding bolsters development of canine longevity drugMarch 25, 2024The latest financing round brings the total funds raised for the first FDA-approved dog lifespan extension drug to $125M
The FDA reminds veterinarians, pet owners of recalled eye dropsMarch 13, 2024The agency reports receiving at least one ‘adverse event’ in an animal related to the use of these products.
